Literature DB >> 19572269

Development and validation of the Singing Voice Handicap-10.

Seth M Cohen1, Melissa Statham, Clark A Rosen, Thomas Zullo.   

Abstract

OBJECTIVES/HYPOTHESIS: To develop a shortened version of the validated health status instrument for singers, the Singing Voice Handicap Index (SVHI). STUDY
DESIGN: Prospective item analysis of the SVHI in patients with singing voice problems and creation and validation of an abbreviated SVHI, the SVHI-10.
METHODS: Patients presenting to two tertiary care voice clinics prospectively completed the SVHI. Principal component analysis was performed. Individual item to total correlations were calculated, and individual items were also evaluated for bipolar response patterns. A clinical consensus conference prioritized each individual item. Items were then eliminated, and the internal consistency was evaluated. A second cohort of patients with singing voice problems completed the Voice Handicap Index-10 (VHI-10) and SVHI-10 at two time points. Singers without voice problems also completed the SVHI-10. SVHI-10 scores were compared between the groups, correlations between the SVHI-10 and VHI-10 were performed, and test-retest reliability of the SVHI-10 assessed.
RESULTS: Singers with voice problems had worse SVHI-10 scores than normal singers (P < .0001, t test). Test-retest reliability was high (Spearman correlation = 0.86, P < .001). Internal consistency of the SVHI-10 demonstrated a Cronbach alpha of .94, and the correlation between the SVHI-10 and VHI-10 was 0.7 (P < .001, Spearman correlation).
CONCLUSIONS: The SVHI-10 is a valuable instrument to assess self-perceived handicap associated with singing voice problems with reduced patient burden.

Entities:  

Mesh:

Year:  2009        PMID: 19572269     DOI: 10.1002/lary.20580

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  [Medical treatment of singers' voices].

Authors:  B Richter; M Echternach
Journal:  HNO       Date:  2011-06       Impact factor: 1.284

2.  Assessment of Clinical and Social Characteristics That Distinguish Presbylaryngis From Pathologic Presbyphonia in Elderly Individuals.

Authors:  Brianna K Crawley; Salem Dehom; Cedric Thiel; Jin Yang; Andrea Cragoe; Iman Mousselli; Priya Krishna; Thomas Murry
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-07-01       Impact factor: 6.223

3.  Psychometric Analysis of an Ecological Vocal Effort Scale in Individuals With and Without Vocal Hyperfunction During Activities of Daily Living.

Authors:  Katherine L Marks; Alessandra Verdi; Laura E Toles; Kaila L Stipancic; Andrew J Ortiz; Robert E Hillman; Daryush D Mehta
Journal:  Am J Speech Lang Pathol       Date:  2021-10-19       Impact factor: 4.018

4.  Change of Voice Handicap Index after treatment of benign laryngeal disorders.

Authors:  Marijn Stuut; Robin E A Tjon Pian Gi; Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-20       Impact factor: 2.503

5.  A visual analog scale for patient-reported voice outcomes: The VAS voice.

Authors:  Matthew R Naunheim; Jennifer B Dai; Benjamin J Rubinstein; Leanne Goldberg; Alan Weinberg; Mark S Courey
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-12-17

6.  Relationships Among Personality, Daily Speaking Voice Use, and Phonotrauma in Adult Female Singers.

Authors:  Laura E Toles; Nelson Roy; Stephanie Sogg; Katherine L Marks; Andrew J Ortiz; Annie B Fox; Daryush D Mehta; Robert E Hillman
Journal:  J Speech Lang Hear Res       Date:  2021-11-03       Impact factor: 2.674

7.  Perceptions of Vocal Performance Impairment in Singers with and without Hearing Loss.

Authors:  Gurmehr Brar; Einav Silverstein; Melissa Zheng; M Eugenia Castro; Raymond Goldsworthy; Lynn Helding; Michael M Johns
Journal:  J Voice       Date:  2021-07-24       Impact factor: 2.300

8.  Effectiveness of oral motor respiratory exercise and vocal intonation therapy on respiratory function and vocal quality in patients with spinal cord injury: a randomized controlled trial.

Authors:  Xiao-Ying Zhang; Yi-Chuan Song; Chang-Bin Liu; Chuan Qin; Song-Huai Liu; Jian-Jun Li
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.